Wilsons Advisory is pleased to have acted as Joint Lead Manager to the successful $45m capital raising for global communications SaaS provider Whispir (WSP:ASX). The capital raised provides Whispir with additional growth capital to pursue its significant global growth opportunities in ANZ, Asia and North America.

Wilsons Advisory are delighted to have acted Joint Lead Manager and Joint Underwriter on the $47m IPO of Top Shelf International, which listed on the ASX on the 10th of December 2020. Top Shelf is a Melbourne based producer and marketer of high-quality Australian spirit-based beverage brands, with an ambition to create high quality, authentic Aussie spirit brands.

Congratulations to Martin Perelman, Advent Partners and the whole SILK Laser Clinics Australia team on the successful Initial Public Offer (“IPO”) of SLK on the ASX. Shares in the company closed at $3.58 on day one of trading, reflecting a 4% increase on list price, driven by strong investor demand.

Wilsons Advisory are delighted to have acted Joint Lead Manager and Joint Underwriter on the $47m IPO of Top Shelf International, which today lists on the ASX.

SILK Laser Australia Limited (“SILK”) has lodged its Prospectus with ASIC for an Initial Public Offer (“IPO”). Wilsons Advisory is acting as Joint Lead Manager and Underwriter to the IPO. The IPO will raise approximately $83.5 million at an indicative market capitalisation of approximately $162.5 million.

Soft tissue regeneration company Aroa, with Wilsons Advisory acting as Joint Lead Manager and Joint Underwriter, recently completed a $45 million initial public offering (IPO), positioning the business to capitalise on its leading technology and market opportunity.

Wilsons Advisory is pleased to have acted as Joint Lead Manager to Antisense Therapeutics Ltd.'s (“Antisense”; ASX.ANP) recent $7.3 million capital raising.

Wilsons Advisory is pleased to have acted as Joint Lead Manager and Bookrunner to the $77.4 million selldown by existing shareholders of Whispir (WSP:ASX), following the release of shares from escrow restrictions set at Whispir’s IPO in June 2019. A total of 20.3 million shares representing 19.6% of Whispir’s shares on issue were sold to new and existing domestic and international investors.